Keywords: despite, tough, astrazeneca, full-year, results, fall, target

Despite a tough year, AstraZeneca's full-year 2004 results fall in target range

Article | 07 February 2005

• Print This

"2004 was quite a year," was the statement that kicked off AstraZeneca's chief executive Sir Tom McKillop's opening speech at the ...

Enjoying this article? To continue reading you need to login or subscribe.